Glaze Life Sciences is developing a non invasive device to monitor the blood glucose level.
Glaze Life Sciences has raised $540K in total funding. The most recent round was Convertible Note. The last funding was announced in February 2024.
Glaze Life Sciences's investors include BioInnovation Institute.
Glaze Life Sciences is headquartered in Copenhagen, Denmark.
Glaze Life Sciences is developing a non invasive device to monitor the blood glucose level.
Glaze Life Sciences is at the Convertible Note stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Glaze Life Sciences — Funding & Investors." VCBacked, February 29, 2024, https://www.vcbacked.co/company/glaze-life-sciences. Accessed August 14, 2026.
VCBacked. (2024). Glaze Life Sciences — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/glaze-life-sciences
{{cite web |title=Glaze Life Sciences — Funding & Investors |url=https://www.vcbacked.co/company/glaze-life-sciences |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated